Pipali (Long Pepper) for Anti-Inflammatory

Research suggests that long pepper and its key bioactive compounds — particularly piperine, piperlongumine, and guineensine — demonstrate anti-inflammatory activity across a range of preclinical settings, with studies pointing to multiple proposed mechanisms including suppression of the NF-κB signaling pathway, inhibition of COX-2 enzyme activity, modulation of the endocannabinoid system, and interference with necroptosis-related cell death pathways. The available evidence consists entirely of laboratory cell studies, animal models, one computational docking analysis, and a review chapter, with no randomized controlled trials or clinical studies in humans, which represents a significant limitation in drawing conclusions about real-world efficacy. Studies indicate that both isolated compounds and whole extracts of long pepper reduce markers of inflammation such as pro-inflammatory cytokines, nitric oxide release, and vascular permeability in experimental models, and one study using a multi-herb essential oil blend further complicates attribution of effects specifically to long pepper. Overall, while the body of preclinical research is consistently supportive in its direction, the absence of human trial data means the extent to which these findings translate to meaningful anti-inflammatory effects in people remains an open question.